glutathione cancer growth NRF2 supports non-small cell lung independently of CBP/p300-enhanced synthesis | EMBO Reports Glutathione: Lights and Shadows in

Proitsi P, Kim M, Whiley L, Simmons A, Sattlecker M, Velayudhan L, Lupton MK, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Powell JF, Dobson RJ, Legido-Quigley C

Emerging trends that may influence the better delivery of breast cancer drugs to the target sites Nanotechnology uses nanoparticles to deliver drugs to target sites

A phase II randomized controlled trial demonstrated that deferiprone, an iron chelator, significantly reduced iron accumulation in the substantia nigra accompanied by measurable improvements in motor function assessed by UPDRS [259]

Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal A, Cederholm T, Cruz-Jentoft A, Krznari Z, Nair KS, Singer P, Teta D, Tipton K, Calder PC